Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Pain Medicine (Malden, Mass.)|September 22, 2016
Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis PainAngelo Iacobellis, Davide Seripa, Orazio Palmieri, et al.
Parkinson'S Disease|June 14, 2016
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's DiseaseAntonio Daniele, Francesco Panza, Antonio Greco, et al.
Progress in Lipid Research|June 28, 2011
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathologyVincenza Frisardi, Francesco Panza, Davide Seripa, et al.
Ageing Research Reviews|July 6, 2010
Pharmacogenetics of cytochrome P450 (CYP) in the elderlyDavide Seripa, Andrea Pilotto, Francesco Panza, et al.
Rejuvenation Research|October 1, 2011
The genetics of the human APOE polymorphismDavide Seripa, Grazia D'Onofrio, Francesco Panza, et al.
Frontiers in Aging Neuroscience|September 11, 2014
Nutrition, frailty, and Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Michele Giannini, et al.
Kidney & Blood Pressure Research|August 14, 2014
Frailty, disability and physical exercise in the aging process and in chronic kidney diseaseAntonio Greco, Giulia Paroni, Davide Seripa, et al.
Expert Opinion on Pharmacotherapy|June 2, 2020
Can pharmacotherapy effectively reduce Alzheimer's related agitation?Madia Lozupone, Maddalena La Montagna, Rodolfo Sardone, et al.
Molecular Neurobiology|July 7, 2018
Klotho at the Edge of Alzheimer's Disease and Senile DepressionGiulia Paroni, Francesco Panza, Salvatore De Cosmo, et al.
Expert Opinion on Biological Therapy|April 20, 2011
Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroadsFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Pain Medicine (Malden, Mass.)|September 22, 2016
Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis PainAngelo Iacobellis, Davide Seripa, Orazio Palmieri, et al.
Parkinson'S Disease|June 14, 2016
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's DiseaseAntonio Daniele, Francesco Panza, Antonio Greco, et al.
Progress in Lipid Research|June 28, 2011
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathologyVincenza Frisardi, Francesco Panza, Davide Seripa, et al.
Ageing Research Reviews|July 6, 2010
Pharmacogenetics of cytochrome P450 (CYP) in the elderlyDavide Seripa, Andrea Pilotto, Francesco Panza, et al.
Rejuvenation Research|October 1, 2011
The genetics of the human APOE polymorphismDavide Seripa, Grazia D'Onofrio, Francesco Panza, et al.
Frontiers in Aging Neuroscience|September 11, 2014
Nutrition, frailty, and Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Michele Giannini, et al.
Kidney & Blood Pressure Research|August 14, 2014
Frailty, disability and physical exercise in the aging process and in chronic kidney diseaseAntonio Greco, Giulia Paroni, Davide Seripa, et al.
Expert Opinion on Pharmacotherapy|June 2, 2020
Can pharmacotherapy effectively reduce Alzheimer's related agitation?Madia Lozupone, Maddalena La Montagna, Rodolfo Sardone, et al.
Molecular Neurobiology|July 7, 2018
Klotho at the Edge of Alzheimer's Disease and Senile DepressionGiulia Paroni, Francesco Panza, Salvatore De Cosmo, et al.
Expert Opinion on Biological Therapy|April 20, 2011
Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroadsFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Pageof 23